Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ajm300
2. L-phenylalanine, N-(2,6-dichlorobenzoyl)-4-(6-(dimethylamino)-1,4-dihydro-1-methyl-2,4-dioxo-3(2h)-quinazolinyl)-, Methyl Ester
3. Methyl N-(2,6-dichlorobenzoyl)-4-(6-(dimethylamino)-1-methyl-2,4-dioxo-1,4-dihydro-3(2h)-quinazolinyl)-l-phenylalaninate
1. 401905-67-7
2. Oyk17dyo9m
3. Carotegrast Methyl (jan)
4. Ajm300
5. Carotegrast Methyl [jan]
6. (2s)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-(1-methyl-2,4-dioxoquinazolin-3-yl)phenyl]propanoic Acid
7. Methyl (2s)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[6-(dimethylamino)-1-methyl-2,4-dioxoquinazolin-3-yl]phenyl]propanoate
8. Unii-oyk17dyo9m
9. Yl]phenyl]propanoate
10. Schembl10329624
11. Gtpl10510
12. Dtxsid60193189
13. Hy-124290
14. Cs-0086113
15. D09799
16. (dimethylamino)-1-methyl-2,4-dioxoquinazolin-3-
17. Q27285918
18. Methyl (2s)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[6-
19. L-phenylalanine, N-(2,6-dichlorobenzoyl)-4-(6-(dimethylamino)-1,4-dihydro-1-methyl-2,4- Dioxo-3(2h)-quinazolinyl)-, Methyl Ester
20. L-phenylalanine, N-(2,6-dichlorobenzoyl)-4-(6-(dimethylamino)-1,4-dihydro-1-methyl-2,4-dioxo-3(2h)-quinazolinyl)-, Methyl Ester
21. N-(2,6-dichlorobenzoyl)-4-[6-(dimethylamino)-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3-yl]-l-phenylalanine Methyl Ester
| Molecular Weight | 569.4 g/mol |
|---|---|
| Molecular Formula | C28H26Cl2N4O5 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 8 |
| Exact Mass | 568.1280253 g/mol |
| Monoisotopic Mass | 568.1280253 g/mol |
| Topological Polar Surface Area | 99.3 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 918 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
Details:
Primary endpoint was achieved in Phase III clinical study (AJM300/CT3) of AJM300 (nonproprietary name: carotegrast methyl), which EA Pharma and Kissei Pharmaceutical have developed for treatment of ulcerative colitis.
Lead Product(s): Carotegrast Methyl
Therapeutic Area: Gastroenterology Brand Name: AJM300
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: EA Pharma
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 13, 2021
Lead Product(s) : Carotegrast Methyl
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : EA Pharma
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Primary endpoint was achieved in Phase III clinical study (AJM300/CT3) of AJM300 (nonproprietary name: carotegrast methyl), which EA Pharma and Kissei Pharmaceutical have developed for treatment of ulcerative colitis.
Brand Name : AJM300
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 13, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
APIs
Reply
23 Nov 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Carotegrast Methyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carotegrast Methyl, including repackagers and relabelers. The FDA regulates Carotegrast Methyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carotegrast Methyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Carotegrast Methyl supplier is an individual or a company that provides Carotegrast Methyl active pharmaceutical ingredient (API) or Carotegrast Methyl finished formulations upon request. The Carotegrast Methyl suppliers may include Carotegrast Methyl API manufacturers, exporters, distributors and traders.
Carotegrast Methyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carotegrast Methyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carotegrast Methyl GMP manufacturer or Carotegrast Methyl GMP API supplier for your needs.
A Carotegrast Methyl CoA (Certificate of Analysis) is a formal document that attests to Carotegrast Methyl's compliance with Carotegrast Methyl specifications and serves as a tool for batch-level quality control.
Carotegrast Methyl CoA mostly includes findings from lab analyses of a specific batch. For each Carotegrast Methyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carotegrast Methyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Carotegrast Methyl EP), Carotegrast Methyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carotegrast Methyl USP).
LOOKING FOR A SUPPLIER?
Comment (12)
